Abstract
Here, we identified the milk protein α-casein as a novel suppressor of tumor growth and metastasis. Briefly, Met-1 mammary tumor cells expressing α-casein showed a ∼5-fold reduction in tumor growth and a near 10-fold decrease in experimental metastasis. To identify the molecular mechanism(s), we performed genome-wide transcriptional profiling. Interestingly, our results show that α-casein upregulates gene transcripts associated with interferon/STAT1 signaling and downregulates genes associated with "stemness." These findings were validated by immunoblot and FACS analysis, which showed the upregulation and hyperactivation of STAT1 and a decrease in the number of CD44(+) "cancer stem cells."These gene signatures were also able to predict clinical outcome in human breast cancer patients. Thus, we conclude that a lactation-based therapeutic strategy using recombinant α-casein would provide a more natural and non-toxic approach to the development of novel anticancer therapies. © 2012 Landes Bioscience.
Original language | English |
---|---|
Pages (from-to) | 3972-3982 |
Number of pages | 10 |
Journal | Cell Cycle |
Volume | 11 |
Issue number | 21 |
DOIs | |
Publication status | Published - 1 Nov 2012 |
Keywords
- Breast cancer
- Cancer stem cells
- Casein
- Interferon signaling
- Lactation
- Metastasis
- Milk proteins
- STAT1